Quotient Wealth Partners LLC Purchases 295 Shares of Corteva, Inc. $CTVA

Quotient Wealth Partners LLC grew its position in shares of Corteva, Inc. (NYSE:CTVA) by 7.9% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 4,006 shares of the company’s stock after buying an additional 295 shares during the quarter. Quotient Wealth Partners LLC’s holdings in Corteva were worth $299,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Maryland Capital Advisors Inc. bought a new stake in Corteva during the second quarter worth about $29,000. Valley National Advisers Inc. grew its stake in Corteva by 85.9% during the first quarter. Valley National Advisers Inc. now owns 526 shares of the company’s stock worth $33,000 after buying an additional 243 shares during the last quarter. DHJJ Financial Advisors Ltd. grew its stake in Corteva by 132.2% during the second quarter. DHJJ Financial Advisors Ltd. now owns 527 shares of the company’s stock worth $39,000 after buying an additional 300 shares during the last quarter. Richardson Capital Management LLC bought a new stake in Corteva during the first quarter worth about $37,000. Finally, von Borstel & Associates Inc. bought a new stake in Corteva during the first quarter worth about $44,000. 81.54% of the stock is owned by institutional investors.

Corteva Trading Up 0.7%

CTVA opened at $61.45 on Monday. The firm’s fifty day moving average is $69.44 and its two-hundred day moving average is $68.97. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.23 and a current ratio of 1.68. The firm has a market cap of $41.73 billion, a PE ratio of 29.98, a price-to-earnings-growth ratio of 1.40 and a beta of 0.76. Corteva, Inc. has a twelve month low of $53.40 and a twelve month high of $77.41.

Corteva (NYSE:CTVA) last posted its earnings results on Wednesday, August 6th. The company reported $2.20 earnings per share for the quarter, topping the consensus estimate of $1.89 by $0.31. Corteva had a net margin of 8.16% and a return on equity of 8.68%. The company had revenue of $6.46 billion for the quarter, compared to analyst estimates of $6.26 billion. During the same period last year, the business posted $1.83 earnings per share. The business’s revenue for the quarter was up 5.6% compared to the same quarter last year. Equities research analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Tuesday, September 2nd were given a dividend of $0.18 per share. This is a positive change from Corteva’s previous quarterly dividend of $0.17. This represents a $0.72 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend was Tuesday, September 2nd. Corteva’s payout ratio is currently 35.12%.

Insider Activity

In other news, EVP Robert D. King sold 37,280 shares of the stock in a transaction on Friday, August 29th. The shares were sold at an average price of $74.20, for a total transaction of $2,766,176.00. Following the completion of the sale, the executive vice president owned 49,262 shares of the company’s stock, valued at $3,655,240.40. This represents a 43.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.15% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

CTVA has been the topic of several research analyst reports. UBS Group decreased their price objective on shares of Corteva from $91.00 to $85.00 and set a “buy” rating on the stock in a research note on Monday, October 6th. Morgan Stanley set a $84.00 target price on shares of Corteva in a research report on Monday, September 15th. Wells Fargo & Company reduced their target price on shares of Corteva from $83.00 to $80.00 and set an “overweight” rating on the stock in a research report on Thursday. Mizuho reduced their target price on shares of Corteva from $85.00 to $78.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 8th. Finally, Argus cut their price objective on shares of Corteva from $83.00 to $80.00 and set a “buy” rating on the stock in a report on Monday, October 13th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $80.31.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.